Human Recombinant NAP-2 (from E. coli)

Supplier: Shenandoah Biotechnology
Ratings: (No Reviews)

Total Ratings: 0
Avg. Ratings: 0.0 out of 5

100-210-5UG 100-210-100UG 100-210-500UG 100-210-1MG 100-210-25UG
SHBT100-210-5UGEA 68.8 GBP
SHBT100-210-5UG SHBT100-210-100UG SHBT100-210-500UG SHBT100-210-1MG SHBT100-210-25UG
Human Recombinant NAP-2 (from E. coli)
Proteins and Peptides

Neutrophil activating peptide 2 (NAP-2), also known as CXCL7, is a member of the CXC family of chemokines. NAP-2 is a carboxyl-terminal fragment produced by proteolytic cleavage of the platelet basic protein (PBP). NAP-2 is released from platelets and binds to the receptors CXCR1 and CXCR2 to chemoattract and activate neutrophils during inflammatory events.


  • High quality
  • Low endotoxin
  • Affordable


Caution: For research use only.

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR